0000950170-22-011094.txt : 20220602 0000950170-22-011094.hdr.sgml : 20220602 20220602171554 ACCESSION NUMBER: 0000950170-22-011094 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220601 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20220602 DATE AS OF CHANGE: 20220602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lucira Health, Inc. CENTRAL INDEX KEY: 0001652724 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 272491037 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39976 FILM NUMBER: 22991960 BUSINESS ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (814) 574-1546 MAIL ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: DiAssess Inc. DATE OF NAME CHANGE: 20150908 8-K 1 lhdx-20220601.htm 8-K 8-K
0001652724false00016527242022-06-012022-06-01

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 01, 2022

 

 

Lucira Health, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39976

27-2491037

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1412 62nd Street

 

Emeryville, California

 

94608

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 510 350-8071

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

LHDX

 

NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 1, 2022, Lucira Health, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”). At the 2022 Annual Meeting, the Company’s stockholders voted on the following proposals and cast their votes as set forth below. A more detailed description of each proposal is set forth in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 20, 2022.

Proposal 1. Election of Directors

The Company’s stockholders elected the individuals listed below as Class I Directors, to serve until the Company’s 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier resignation or removal. The final voting results are as follows:

 

For

 

Against

 

Withheld

 

Broker Non-Votes

 

David Lamond

 

17,975,889

 

 

—

 

 

916,277

 

 

7,698,574

 

Alison McCauley

 

18,166,531

 

 

—

 

 

725,635

 

 

7,698,574

 

Tuff Yen

 

18,631,564

 

 

—

 

 

260,602

 

 

7,698,574

 

 

Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection of BDO USA, LLP by the Audit Committee of the Company’s Board of Directors as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. The final voting results are as follows:

For

 

Against

 

Abstain

 

Broker Non-Votes

 

 

26,468,740

 

 

63,152

 

 

58,848

 

 

—

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Lucira Health, Inc.

 

 

 

 

Date:

June 2, 2022

By:

/s/ Daniel George

 

 

 

Daniel George
Chief Financial Officer

 

 EX-101.LAB 2 lhdx-20220601_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications EX-101.PRE 3 lhdx-20220601_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 4 lhdx-20220601.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document And Entity Information
Jun. 01, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 01, 2022
Entity Registrant Name Lucira Health, Inc.
Entity Central Index Key 0001652724
Entity Emerging Growth Company true
Entity File Number 001-39976
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 27-2491037
Entity Address, Address Line One 1412 62nd Street
Entity Address, City or Town Emeryville
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94608
City Area Code 510
Local Phone Number 350-8071
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol LHDX
Security Exchange Name NASDAQ
XML 6 lhdx-20220601_htm.xml IDEA: XBRL DOCUMENT 0001652724 2022-06-01 2022-06-01 0001652724 false 8-K 2022-06-01 Lucira Health, Inc. DE 001-39976 27-2491037 1412 62nd Street Emeryville CA 94608 510 350-8071 false false false false Common Stock, par value $0.001 per share LHDX NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports lhdx-20220601.htm lhdx-20220601.xsd lhdx-20220601_lab.xml lhdx-20220601_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "lhdx-20220601.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "lhdx-20220601.htm" ] }, "labelLink": { "local": [ "lhdx-20220601_lab.xml" ] }, "presentationLink": { "local": [ "lhdx-20220601_pre.xml" ] }, "schema": { "local": [ "lhdx-20220601.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lhdx", "nsuri": "http://www.lucirahealth.com/20220601", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "lhdx-20220601.htm", "contextRef": "C_6da900d9-1e84-4497-982b-b130195fff3e", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "role": "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "lhdx-20220601.htm", "contextRef": "C_6da900d9-1e84-4497-982b-b130195fff3e", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.lucirahealth.com/20220601/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0000950170-22-011094-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-22-011094-xbrl.zip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